1 |
Payrastre, B., Missy, K., Trumel, C., Bodin, S., Plantavid, M. and Chap, H. (2000) The integrin alpha IIb/beta 3 in human platelet signal transduction. Biochem. Pharmacol. 60: 1069-1074.
DOI
|
2 |
Jackson, S. P. (2011) Arterial thrombosis?insidious, unpredictable and deadly. Nat. Med. 17: 1423-1436.
DOI
|
3 |
Schwartz, S. M., Heimark, R. L. and Majesky, M. W. (1990) Developmental mechanisms underlying pathology of arteries. Physiol. Rev. 70: 1177-1209.
DOI
|
4 |
Phillips, D. R., Nannizzi-Alaimo, L. and Prasad, K. S. (2001) Beta3 tyrosine phosphorylation in alphaIIbbeta3 (platelet membrane GP IIb-IIIa) outside-in integrin signaling. Thromb. Haemost. 86: 246-258.
DOI
|
5 |
Morello, F., Perino, A. and Hirsch, E. (2009) Phosphoinositide 3-kinase esculetin in the vascular system. Cardiovasc. Res. 82: 261-271.
DOI
|
6 |
Jennings, L. K. (2009) Role of platelets in atherothrombosis. Am. J. Cardiol. 103: 4A-10A.
DOI
|
7 |
Sabatine, M. S. and Jang, I. K. (2000) The use of glycoprotein IIb/IIIa inhibitors in patients with coronary artery disease. Am. J. Med. 109: 224-237.
DOI
|
8 |
Cattanco, M., Tenconi, P. M., Lecchi, A. and Mannucci, P. M. (1991) In vitro effects of picotamide on human platelet aggregation, the release re- action and thromboxane B2 production. Thromb. Res. 62: 717-724.
DOI
|
9 |
Su, C. Y., Shiao, M. S. and Wang, C. T. (1999) Differential effects of ganodermic acid S on the thromboxane A2-signaling pathways in human platelets. Biochem. Pharmacol. 58: 587-595.
DOI
|
10 |
Bugaud, F., Nadal-Wollbold, F., Levy-Toledano, S., Rosa, J. P. and Bryckaert, M. (1990) Regulation of c-jun-NH2 terminal kinase and extracellular-signal regulated kinase in human platelets. Blood 94: 3800-3805.
DOI
|
11 |
Kramer, R. M., Roberts, E. F., Strifler, B. A. and Johnstone, E. M. (1995) Thrombin induces activation of p38 MAP kinase in human platelets. J. Biol. Chem. 270: 27395-27398.
DOI
|
12 |
Nadal-Wollbold, F., Pawlowski, M., Levy-Toledano, S., Berrou, E., Rosa, J. P. and Bryckaert, M. (2002) Platelet ERK2 activation by thrombin is dependent on calcium and conventional protein kinases C but not Raf-1 or B-Raf. FEBS Lett. 531: 475-482.
DOI
|
13 |
Patrono, C. (1994) Aspirin as an antiplatelet drug. N. Engl. J. Med. 330: 1287-1294.
DOI
|
14 |
Adam, F., Kauskot, A., Rosa, J. P. and Bryckaert, M. (2008) Mitogen activated protein kinases in hemostasis and thrombosis. J. Thromb. Haemost. 6: 2007-2016.
DOI
|
15 |
Flevaris, P., Li, Z., Zhang, G., Zheng, Y., Liu, J. and Du, X. (2009) Two distinct roles of mitogen-activated protein kinases in platelets and a novel Rac1-MAPK-dependent integrin outside-in retractile signaling pathway. Blood 13: 893-901.
|
16 |
Chuang, W. Y., Kung, P. H., Kuo, C. Y. and Wu, C. C. (2013) Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidylinositol 3-kinase/Akt pathway. Thromb. Haemost. 109: 1120-1130.
DOI
|
17 |
Esu, E. B., Effa, E. E., Opie, O. N. and Meremikwu, M. M. (2019). Artemether for severe malaria, Cochrane Database Syst. Rev. 6: CD010678.
|
18 |
Irfan, M., Jeong, D., Saba, E., Kwon, H. W., Shin, J. H., Jeon, B. R., Kim, S., Kim, S. D., Lee, D. H., Nah, S. Y. and Rhee, M. H. (2019) Gintonin modulates platelet function and inhibits thrombus formation via impaired glycoprotein VI signaling. Platelets 30: 589-598.
DOI
|
19 |
Saeed, M. E., Krishna, S., Greten, H. J., Kremsner, P. G. and Efferth, T. (2016) Antischistosomal activity of artemisinin derivatives in vivo and in patients. Pharmacological. Research. 110: 216-226.
DOI
|
20 |
Shin, J. H., Kwon, H. W. and Lee, D. H. (2019) Ginsenoside F4 inhibits platelet aggregation and thrombus formation by dephosphorylation of IP3RI and VASP. J. Appl. Biol. Chem. 62: 93-100.
DOI
|
21 |
McNicol, A. and Jackson, E. C. (2003) Inhibition of the MEK/ERK pathway has no effect on agonist-induced aggregation of human platelets. Biochem. Pharmacol. 65: 1243-1250.
DOI
|